Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|June 12, 1992
Synthesis and thromboxane A2/prostaglandin H2 receptor antagonistic activity of phenol derivativesS Fukumoto, M Shiraishi, Z Terashita, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivoZ Terashita, Y Imura, M Takatani, et al.
Biochemical and Molecular Medicine|December 1, 1995
Binding properties of fibrinogen receptor GPIIb-IIIa purified from human erythroleukemia cellsK Yoshimura, T Miyazaki, N Furuyama, et al.
Chemical & Pharmaceutical Bulletin|March 1, 1994
Synthesis and platelet-activating factor (PAF)-antagonistic activities of 1,4-disubstituted piperazine derivativesH Fukushi, H Mabuchi, K Itoh, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodentsZ Terashita, M Kawamura, M Takatani, et al.
Life Sciences|April 25, 1983
CV-3988 - a specific antagonist of platelet activating factor (PAF)Z Terashita, S Tsushima, Y Yoshioka, et al.
Journal of Medicinal Chemistry|September 1, 1989
Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluationM Shiraishi, K Kato, S Terao, et al.
Journal of Lipid Mediators and Cell Signalling|May 1, 1994
Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogsM Kawamura, T Kitayoshi, Z Terashita, et al.
Pageof 6